Mankind Pharma Limited has informed the Exchange about Schedule of meet
MANKIND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mankind Pharma has informed the stock exchanges that its officials will participate in the 21st Annual Global Investor Conference scheduled for September 1, 2025, in Mumbai. The participation will include one-on-one and group meetings with investors. The company has clarified that no unpublished price sensitive information (UPSI) will be shared during the conference. The schedule is subject to change due to unforeseen circumstances.
This is a routine regulatory disclosure with no material impact on the stock. It signals continued investor engagement but does not indicate any new business developments or strategic announcements.